The DPP-4 inhibitor sitagliptin improves glycaemic control and early-stage diabetic nephropathy in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed-loop system: a randomised controlled trial
Elbarbary, Nancy S, Ismail, Eman A, El-Hamamsy, Manal H, Ibrahim, Marwa Z, Elkholy, Amal A
Published in Diabetologia (14.09.2024)
Published in Diabetologia (14.09.2024)
Get full text
Journal Article